PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Choosing First-Line Therapy for Patients With Advanced NSCLC Harbouring Activating EGFR Mutations: What Can We Learn From LUX-Lung 7?
Choosing First-Line Therapy for Patients With Advanced NSCLC Harbouring Activating EGFR Mutations: What Can We Learn From LUX-Lung 7?